Wrong Blood Transfusion: Kerala Health Dept Takes Action Against Three

Malappuram: The Kerala Health Department on Saturday took action against two doctors and a staff nurse at the Government Women and Children hospital at Ponnani near here over an alleged incident of wrongful blood transfusion on a pregnant woman.

A 26-year old woman was allegedly given the wrong blood group during transfusion on Thursday.

The two doctors, who were working at the hospital on contract basis, were terminated from service, the Health Minister’s office said.

A staff nurse of the hospital was suspended pending enquiry, according to a Health department official.

The alleged incident happened on September 28 evening but was immediately stopped after the patient complained of shivering.

Hospital sources told PTI that the eight-month pregnant woman with ‘O’ negative blood group was wrongly given B positive blood group.

The woman was immediately shifted to Thrissur medical college and her condition is said to be stable.

Related Posts

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

The Team Meticulously averted the Risk of Thrombosis, Husband was Donor Delhi/NCR : Doctors at Yashoda Medicity have successfully performed a high-risk kidney transplant in a 28-year-old woman with Antiphospholipid…

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta, a UK-based clinical stage biotech, is differentiated clinical-stage oncology specialist, increasingly defined by continuing progress with its second-generation pre|CISION tumour-activated Peptide Drug Conjugate (PDC) platform. The lead Gen Two…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Puresta launches EVERQ, AI-powered skin-health platform

Puresta launches EVERQ, AI-powered skin-health platform

Stem cell therapy for autism only in approved clinical trials: Centre

Stem cell therapy for autism only in approved clinical trials: Centre